asa guidelines for glp 1 agonists 🔸 Should GLP-1 RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f Frontiers | Mechanisms of action

This makes it a promising option for those seeking significant and sustained weight loss

515,516,517 GLP-1 may improve the livers antioxidant capacity and metabolic function by activating Sirt1, thereby helping to alleviate the pathological changes associated with NASH

In vitro , the DPP4 release increased substantially during fat cell differentiation, and comparison with preadipocytes and adipose tissue, macrophages showed that adipocytes most likely represent the major source of DPP4 released from the intact organ to the circulation

Jennings L, Nestor L, Molloy O, Hughes R, Moriarty B, Kirby B

Multiple studies, usually done during endoscopies (EGDs) with or without colonoscopies, have shown that patients on GLP-1 receptor agonists have residual gastric contents when fasting from solids for 8 hours (70% of patients, n=10) and when fasting from solids for up to 16 hours (13.1% after 10 hr, n=84

Binding mechanisms: DPP-4 inhibitors' binding modes can be grouped into three main classes that interact in different manners with specific sites on the DPP-4 enzyme: Class 1: Saxagliptin and vildagliptin bind to specific sites on the DPP-4 molecule, saxagliptin/S1 and saxagliptin/S2, and form a bond with Ser630